Sponsor or institution
Clinical trials and research at HK inno.N Corporation
As of November 12, 2026, Find a Trial lists 5 clinical trials run by HK inno.N Corporation that are recruiting, in South Korea. 3 were first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Observational look at how Kremezin works in adults with advanced chronic kidney disease | — | Seoul | Recruiting | Nov 10, 2026 |
| Observational study of achieving LDL targets with Rovazet tablets in dyslipidemia | — | Seoul | Recruiting | Nov 9, 2026 |
| Maintenance therapy with K-CAB 25 mg for GERD patients after initial treatment | — | Seoul | Recruiting | Nov 6, 2026 |
| Gerd symptoms with tegoprazan treatment in adults | — | Seoul | Recruiting | Jul 1, 2026 |
| Topical IN-115314 Ointment in mild to moderate atopic dermatitis | Phase 2 | Ansan, ALL | Recruiting | Jul 18, 2025 |
All recruiting trials (5)
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Observational study of achieving LDL targets with Rovazet tablets in dyslipidemia
This study follows patients with dyslipidemia who are prescribed Rovazet to see how well reaching LDL targets works in routine care over 48 weeks.
-
Maintenance therapy with K-CAB 25 mg for GERD patients after initial treatment
This study tests whether long-term use of K-CAB 25 mg (tablet or orally disintegrating tablet) helps keep GERD symptoms under control in routine clinical practice.
-
Gerd symptoms with tegoprazan treatment in adults
This study tests whether tegoprazan 50 mg (tablet or dispersible tablet) helps GERD symptoms and is safe in adults who meet criteria.
-
Topical IN-115314 Ointment in mild to moderate atopic dermatitis
This study tests whether IN-115314 ointment (1% or 3%) works and is safe in adults with mild to moderate atopic dermatitis compared with a placebo.
Quick answers
How many clinical trials run by HK inno.N Corporation are recruiting right now?
5, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.